ABT: Abbott Laboratories Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 196,908.71
Enterprise Value ($M) 204,915.71
Book Value ($M) 37,694.00
Book Value / Share 21.72
Price / Book 5.22
NCAV ($M) -11,717.00
NCAV / Share -6.75
Price / NCAV -16.81

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.08
Return on Equity (ROE) 0.16

Liquidity (mrq)
Quick Ratio 1.16
Current Ratio 1.64

Balance Sheet (mrq) ($M)
Current Assets 22,670.00
Assets 73,214.00
Liabilities 34,387.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 40,109.00
Operating Income 6,693.00
Net Income 5,723.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 7,261.00
Cash from Investing -3,133.00
Cash from Financing -7,091.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-13 13G/A Vanguard Group Inc 9.01 0.62
01-26 13G/A BlackRock Inc. 7.70 -3.92

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-K (MARK ONE) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURIT
2023-11-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-28 396,853 3,292,402 12.05
2024-03-27 569,944 7,533,356 7.57
2024-03-26 721,057 7,770,829 9.28
2024-03-25 640,578 6,622,414 9.67

(click for more detail)

Similar Companies
ABBV – AbbVie Inc. ADCT – ADC Therapeutics SA
ANRO – Alto Neuroscience, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Abbott Laboratories